Corporate venture capital rises in 2nd quarter
This article was originally published in Scrip
Executive Summary
Venture capital funds associated with pharmaceutical companies increased their investments in private US health care firms during the second quarter of 2013 with a significant boost for early-stage biotechnology, which has had trouble attracting venture cash.